Cyntegrity, a front-runner in AI-augmented clinical trial risk management solutions, proudly announces its upcoming virtual conference on "Responsible AI in Clinical Trials," scheduled for November 15 and 16. This groundbreaking event is designed to bridge the knowledge gap and stimulate multistakeholder conversations on the responsible application of Artificial Intelligence in clinical research.
Linda Bunschoten, Cyntegrity's Chief Marketing Officer, shed light on the event's unique approach. "Unlike many larger forums that lean towards commercialization, our mission is to instigate genuine dialogue, foster knowledge sharing, and facilitate learning in an intimate setting. This strategy cultivates more real and insightful discussions," she commented.
Artem Andrianov, Ph.D., CEO and founder of Cyntegrity, elaborated on the company's vision, "We're on the brink of some incredible changes in clinical trials, thanks to AI. But let's not get so caught up in the tech that we forget the people it affects. This event is our chance to turn the challenges of ethical AI into opportunities for better healthcare for everyone."
A lineup of esteemed speakers is set to grace the event, such as "The AI Republic" author Danny Goh, Microsoft's Wole Moses, Professor for Artificial Intelligence Kai Eckert, and Wicked Problem Wizard Nechama Katan. Each will contribute their unique blend of academic and industry insights.
Cyntegrity's dedication to community-building around this crucial topic is underscored by its regular provision of complimentary workshops to the Life Sciences sector and educational endeavors like the MyRBQM Academy.
Bunschoten stressed the importance of including regulatory perspectives in these dialogues. "Regulators, especially esteemed bodies like the FDA and EMA, are not only welcome but are seen as key contributors to responsible AI. Their engagement with smaller-scale communities and initiatives is crucial to ensure they remain attuned to the pulse of frontline innovations and emerging voices," she articulated.
Cyntegrity invites Clinical Research industry professionals, researchers, and other stakeholders to partake in this enlightening dialogue: https://responsible-ai-event.rbqm.ai/...
Linda Bunschoten, Cyntegrity's Chief Marketing Officer, shed light on the event's unique approach. "Unlike many larger forums that lean towards commercialization, our mission is to instigate genuine dialogue, foster knowledge sharing, and facilitate learning in an intimate setting. This strategy cultivates more real and insightful discussions," she commented.
Artem Andrianov, Ph.D., CEO and founder of Cyntegrity, elaborated on the company's vision, "We're on the brink of some incredible changes in clinical trials, thanks to AI. But let's not get so caught up in the tech that we forget the people it affects. This event is our chance to turn the challenges of ethical AI into opportunities for better healthcare for everyone."
A lineup of esteemed speakers is set to grace the event, such as "The AI Republic" author Danny Goh, Microsoft's Wole Moses, Professor for Artificial Intelligence Kai Eckert, and Wicked Problem Wizard Nechama Katan. Each will contribute their unique blend of academic and industry insights.
Cyntegrity's dedication to community-building around this crucial topic is underscored by its regular provision of complimentary workshops to the Life Sciences sector and educational endeavors like the MyRBQM Academy.
Bunschoten stressed the importance of including regulatory perspectives in these dialogues. "Regulators, especially esteemed bodies like the FDA and EMA, are not only welcome but are seen as key contributors to responsible AI. Their engagement with smaller-scale communities and initiatives is crucial to ensure they remain attuned to the pulse of frontline innovations and emerging voices," she articulated.
Cyntegrity invites Clinical Research industry professionals, researchers, and other stakeholders to partake in this enlightening dialogue: https://responsible-ai-event.rbqm.ai/...
